| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |